Gustavo Pesquin

Outlook GoDaddy Hosting Amazon AWS Mobile Friendly Google Analytics WordPress.org Google Font API Workday Recruit Google Tag Manager Nginx YouTube Remote

aav adenoassociated virus gene therapy rare disease aav manufacturing molecular medicine nucleic acid epigenome doggybone dna biotechnology research aav technology clinical trials genetic diseases therapeutic pipeline orphan drug designation patient advocacy fda approvals muscular dystrophy neuromuscular disorders cns disorders pompe disease parkinson's disease metabolic diseases cardiovascular diseases investigational treatments rare diseases gene therapy clinical development patient-centered approach biomanufacturing capsid library synthetic promoters research collaborations genetic medicine neurodegenerative diseases adnoviruses monogenic disorders leadership team biotherapy therapeutic gene delivery genome editing disease-modifying therapies pharmaceutical partners patient care clinical development research & development technology platform genetic breakthroughs genetic predisposition innovative therapeutics healthcare innovation life sciences biopharmaceuticals market authorization vaccine technology scientific expertise clinical outcomes biotech industry personalized medicine adeno-associated virus clinical-stage genetic disorders neuromuscular diseases central nervous system huntington's disease limb-girdle muscular dystrophy innovative science transformative therapeutics proprietary technology pro10 cell line gene therapy pipeline regulatory designations collaborations bayer ag subsidiary patient-centric advanced therapies transformative molecular medicines therapeutic advancements biotechnology patient demographics unmet medical needs health care health wellness & fitness hospital & health care